Document is current
Any future updates will be listed below
-
Authors
Klamroth, Robert
Kragh, Nana https://orcid.org/0000-0002-9222-4479
Arnaud, Alix
Guyot, Patricia
Wilson, Amanda
Wojciechowski, Piotr
Wdowiak, Marlena
Margas, Wojciech
Bystrická, Linda
Tosetto, Alberto
-
Funding
Funding for this research was provided by:
Sanofi
- License Information
-
More Information
Article History
Received: 28 May 2024
Accepted: 10 October 2024
First Online: 22 November 2024
<!--Emphasis Type='Bold' removed-->Declarations
:
: Alix Arnaud, Amanda Wilson, and Patricia Guyot are Sanofi employees and may hold stock/stock options in Sanofi. Nana Kragh and Linda Bystrická are employees of Sobi and may hold stock/stock options in Sobi. Piotr Wojciechowski is co-founder at Assignity and an external consultant at Putnam PHMR. Marlena Wdowiak and Wojciech Margas are employees of Putnam PHMR. Robert Klamroth has received honoraria and/or been a member of advisory committees for Bayer, Biomarin, Biotest, CSL Behring, Grifols, Novo Nordisk, Octapharma, Pfizer, Roche/Chugai, Sanofi, Sobi, and Takeda. Alberto Tosetto has no relevant conflicts of interest. Piotr Wojciechowski’s and Wojciech Margas’ affiliation Assignity is now called Clever-Access.
: This is a post hoc analysis and modelling of data already collected and/or published data. Original studies were all approved by the relevant institutional review boards at each study site and were carried out in accordance with the International Conference on Harmonisation good clinical practice guidelines and the Declaration of Helsinki.
